The global pharmaceutical
glass packaging market size is expected to reach USD 22.05 billion
by 2025, according to a new report by Grand View Research, Inc., registering a
CAGR of 6.3% during the forecast period. Spiraling sale of generic drugs in
developed as well as developing economies is projected to drive the demand for
pharmaceutical glass packaging. Glass has a well-defined supply chain in the pharmaceutical
industry and is traditionally used for parenteral drug packaging. Extensive
R&D is being conducted by product manufacturers in order to minimize
negative aspects of glass, such as high susceptibility to breaking and
delamination, as well as to improve the quality & efficacy of the product.
The pharmerging market is anticipated
to witness phenomenal growth owing to favorable government policies and
increased healthcare awareness. Governments of developing nations are expanding
their public or private healthcare coverage and simultaneously making efforts
to minimize out-of-pocket medical expenses for the consumers. Increasing
government efforts to reduce healthcare cost and promotion of low-cost generic
drugs are estimated to fuel the utilization of glass packaging over the coming
years.
Emergence of novel drugs such as
cancer drugs and bio-therapeutics is likely to help the market gain traction
over the coming years. In an effort to safeguard patient health, guidelines for
packaging of biological drugs have been made highly stringent, which
necessitates constant development in the field of pharmaceutical packaging.
Aforementioned factors promote manufacturers to adopt advanced techniques,
thereby driving the market.
In primary pharmaceutical packaging,
glass has an advantage over plastic as plastic production requires raw
materials such as polyethylene, polypropylene, and polystyrene, which are
largely dependent on fluctuating petroleum industry. Manufacturers use soda
lime, quartz, and other additives for manufacturing glass. These raw materials
are easily available in the market by numerous suppliers. Recent developments
in the pharmaceutical glass packaging include launch of Gx Baked-On RTF and an
Omniflex plunger, a prefilled syringe, by Gerresheimer AG in September 2017.
This technology has the ability to minimize particle loads and meet strict
requirements for therapeutic protein products for better deliver of drug.
Browse full research report on Pharmaceutical Glass Packaging Market: https://www.grandviewresearch.com/industry-analysis/pharmaceutical-glass-packaging-market
Further Key Findings from the Report Suggest:
- The vials segment is projected to ascend at a
CAGR of 6.9% in terms of revenue over the forecast period
- The bottles segment dominated the global
pharmaceutical glass packaging market in 2016 in terms of revenue and is
anticipated to witness a CAGR of 4.7% from 2017 to 2025 owing to high
penetration of plastics in the manufacturing of bottles
- The generic drug segment accounted for 69.8% of
the market in 2016 due to rapidly increasing manufacturing volumes of generic
drugs in emerging economies
- Europe is expected to witness considerable growth
during the forecast period owing to constant development in the medical
field aimed at improving health and quality of life
- Some of the key companies present in the market
are Corning Incorporated; Gerresheimer AG; Nipro Pharmapackaging; SCHOTT
AG; Şişecam Group; Arab Pharmaceutical Glass Co.; Beatson Clark; Stevanato
Group; and Owens-Illinois, Inc.
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global pharmaceutical glass
packaging market on the basis of product, drug type, and region:
Pharmaceutical Glass Packaging Product Outlook
(Revenue, USD Million, 2014 - 2025)
- Vials
- Small vials (<30ml)
- Large vials (>30ml)
- Bottles
- Small Bottles (< 1000 ml)
- Large Bottles (> 1000 ml)
- Cartridges & Syringes
- Ampoules
Pharmaceutical Glass Packaging Drug Type Outlook
(Revenue, USD Million, 2014 - 2025)
- Generic
- Branded
- Biologic
Pharmaceutical Glass Packaging Regional Outlook
(Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Asia Pacific
- China
- India
- Japan
- South Korea
- Central & South America
- Brazil
- Middle East & Africa
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment